Literature DB >> 7062044

The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system.

P C Emson, M Goedert, P Horsfield, F Rioux, S St Pierre.   

Abstract

Carboxy- and amino-terminal specific neurotensin antisera have been characterized and used to determine the nature of neurotensin-like immunoreactivity in the rat central nervous system. Using these antisera, together with the separation of neurotensin-like immunoreactivity on reverse-phase HPLC columns, it is clear that the majority of rat central nervous system neurotensin-like immunoreactivity is indistinguishable from the synthetic tridecapeptide, However, smaller amounts of carboxy- and amino-terminal neurotensin-like immunoreactivity were detected, which may correspond to carboxy- and amino-terminal fragments of neurotensin. In addition, using the amino-terminal directed neurotensin antiserum, a detailed distribution of neurotensin-like immunoreactivity in the rat central nervous system is described. Highest amounts were found in the hypothalamus, central amygdaloid nucleus, bed nucleus of the stria terminalis and the substantia gelatinosa of the spinal cord and of the trigeminal region.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062044     DOI: 10.1111/j.1471-4159.1982.tb05340.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats.

Authors:  I Castagliuolo; S E Leeman; E Bartolak-Suki; S Nikulasson; B Qiu; R E Carraway; C Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

2.  Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.

Authors:  D Herve; J P Tassin; J M Studler; C Dana; P Kitabgi; J P Vincent; J Glowinski; W Rostene
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Authors:  C Betancur; M Canton; D Gully; G Vela; D Pélaprat; W Rostène
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

4.  Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions.

Authors:  P E Holtom; P L Needham; G W Bennett; S Aspley
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

5.  Effect of renal failure or portacaval shunt on release of neurotensin in man.

Authors:  E R Eaves; J Hansky
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

6.  Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist.

Authors:  P D Shilling; G Melendez; K Priebe; E Richelson; D Feifel
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

7.  Purification and properties of a neurotensin-degrading endopeptidase from pig brain.

Authors:  P E Millican; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

8.  An immunohistochemical study of somatostatin and neurotensin positive neurons in the septal nuclei of the rat brain.

Authors:  C Köhler; L G Eriksson
Journal:  Anat Embryol (Berl)       Date:  1984

9.  The hypothermic action of carbachol in the rat brain periaqueductal grey area may involve neurotensin.

Authors:  E C Griffiths; P Slater; P S Widdowson
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

10.  The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

Authors:  Paul D Shilling; David Feifel
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.